According to FutureWise analysis the market for single-use bioprocessing in 2023 was US$ 11.95 billion, and is expected to reach US$ 53.9 billion by 2031 at a CAGR of 20.70%.
Single-use bioprocessing, commonly referred to as disposables, pertains to pharmaceutical products and solutions specifically designed for single use before being discarded. Among the most prevalent single-use bioprocessing products are media bags, containers, filtration assemblies, disposable bioreactors, disposable mixers, tubes, connectors, and samplers. These products are extensively utilized in the production of monoclonal antibodies and vaccines, as well as in the cultivation of plant cells and the development of cell therapies. Biopharmaceutical companies and life science research organizations employ these devices to enhance productivity and mitigate the risk of cross-contamination.
In the context of research and manufacturing within the pharmaceutical sector, particularly in personalized medicine, single-use bioprocessing leverages disposable technologies. The adoption of single-use bioprocessing products has surged during both the drug development and biopharmaceutical production phases. This innovation has revolutionized both upstream and downstream processes, rendering them more efficient, streamlined, and cost-effective. Single-use bioprocessing systems utilize sterilized plastic components that are typically sealed through gamma irradiation. Additionally, due to the benefits they offer, regulatory agencies are increasingly endorsing single-use bioprocessing systems. For instance, the Therapeutic Goods Administration (TGA) of Australia permits their use in buffer preparation, mixing, and various upstream processes, and has also recommended good manufacturing practice (GMP) regulations for filters and other single-use bioprocessing equipment.
In light of the growing demand for biologics, the global single-use bioprocessing market is projected to experience substantial growth. The escalating demand for biopharmaceuticals, the increasing acceptance of disposable technologies, the reduced risk of product cross-contamination associated with single-use bioprocessing, and the necessity for minimized floor space are all contributing factors to this market expansion. However, challenges such as extractability and leachability, along with stringent regulations governing the application of disposable systems in the biopharmaceutical industry, present obstacles to market growth. Furthermore, the production of monoclonal antibodies (mAb) utilizing single-use bioprocessing methods constitutes a dominant segment within the global single-use bioprocessing market.
Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=10062%20&type=requestsample
Single-use Bioprocessing Market Segmentation:
By Product
- Media Bags and Containers
- Filtration Assemblies
- Single-use Bioreactors
- Disposable Mixers
- Others
By End User
- Academic and Clinical Research Institutes
- Biopharmaceutical Manufacturers
By Application
- Filtration
- Chromatography
- Membrane Filtration
- Refining and Separation
- Storage
- Cell Culture
- Purification
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Single-use Bioprocessing Market:
- Thermo Fisher Scientific Inc.
- GE Healthcare
- Sartorius Stedim Biotech S.A.
- Merck Millipore
- Danaher Corporation
- 3M Company
- Eppendorf AG
- Hamilton Company
- Corning Incorporated
- Cesco Bioengineering Co. Ltd.
Ask For Discount: https://www.futurewiseresearch.com/checkout.aspx?ReportId=10062&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Single-use Bioprocessing Market By Product, By End User, By Application and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: [email protected]